aml: the next generation of tailored therapy | medscapetv
Published 2 years ago β’ 521 plays β’ Length 6:19Download video MP4
Download video MP3
Similar videos
-
39:06
molecular testing β transplant and treatment strategies in aml
-
2:08
comparing midostaurin to next-generation flt3 inhibitors in the frontline treatment of flt3-itd aml
-
3:28
what is the impact of mrd on the management of patients with πΉπΏπ3-mutated aml
-
1:06
dr. clarke on the mypath test for melanoma
-
1:57
gtb-3550 trike for the treatment of mds & aml
-
1:01
recent and future changes in the landscape of aml: the addition of venetoclax and mrd eradication
-
5:40
current concepts and future developments in t-cell-based immunotherapy of aml
-
3:23
the prognostic impact of pre-transplant mrd-positivity in patients with aml
-
1:04
horizon scan of novel and upcoming aml therapies
-
6:30
medscape - leading & innovating the health information industry
-
2:58
the next generation of biomanufacturing at amgen
-
2:20
emerging trends ophthalmology: doctor-industry partnerships and patient experience: john berdahl, md
-
0:55
dr. dixon on letrozole combined with pathway inhibitors
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
0:54
idh inhibitors and the evolving aml treatment paradigm
-
1:36
meilan han m.d., ms
-
1:44
fast facts about the regulatory approval pathway for biosimilars β amgen science
-
3:02
how have advances in testing impacted aml care?
-
1:34
advances and unmet needs in second-line treatment of dlbcl